Patent Open Access

An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants

Alkoclar, Erdal Can; Yesil, Metehan


Citation Style Language JSON Export

{
  "DOI": "10.82163/sciencerepository.24", 
  "language": "eng", 
  "title": "An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants", 
  "issued": {
    "date-parts": [
      [
        2022, 
        7, 
        8
      ]
    ]
  }, 
  "abstract": "<p>A bioceutical formulation consisting of RNA Polymerase inhibiting and immunomodulatory features- exhibiting Glucopyranoside Analouges for the Adjunctive Treatment of Emerging Covid-19 Subvariants.</p>\n\n<p>&nbsp;</p>\n\n<p>Inventors: Erdal Can Alkoclar &amp; Metehan Yesil</p>", 
  "author": [
    {
      "family": "Alkoclar, Erdal Can"
    }, 
    {
      "family": "Yesil, Metehan"
    }
  ], 
  "version": "1.0", 
  "type": "patent", 
  "id": "24"
}
0
0
views
downloads
All versions This version
Views 00
Downloads 00
Data volume 0 Bytes0 Bytes
Unique views 00
Unique downloads 00

Share

Cite as